Avicenna Alliance: enhanced knowledge, improved decisions, better outcomes

Pharmaceutical Strategy (Pharma) Task Force

Pharmaceutical Strategy (Pharma) Task Force


Pharmaceutical Strategy (Pharma) Task Force

Mission: Accelerate Adoption by Healthcare Stakeholders of In Silico Medicine for Bringing New Medicine to Patients

As the European Authorities are defining the evolution of their pharmaceutical strategies for the next few years, it is crucial to include new and critical technologies for the future. In silico technologies are, without any doubt, an essential tool that should be part of the pharmaceutical future of Europe.

The Pharma Strategy Task Force is acting as a Center of Expertise for In Silico approaches with representatives from Academia and Industry to inform and guide global Competent Authorities in this challenging task and propose concrete avenues, and texts, to engage Europe, US and other regions in the Digitalisation of the Regulatory Pharmaceutical activities”.


  • Address Regulatory Aspects of in silico medicine when used in Pharmaceuticals
  • Advocate use of in silico medicine for Pharmaceuticals for stakeholders
  • Increase confidence of Industry for use of in silico medicine for Pharmaceuticals
  • Identify use of in silico medicine for (specific) target indications and target populations

Yu Feng

Yu Feng

Co-Chair of the Pharmaceutical Strategy (Pharma) Task Force

Associate Professor Oklahoma State University



News Welcome ADSILICO to the Avicenna Alliance!

Welcome ADSILICO to the Avicenna Alliance!

We are delighted to announce that ADSILICO has officially joined the Avicenna Alliance! This partnership marks a significant milestone in our collective mission to advance in silico medicine and foster innovation in healthcare.

News Welcome Bioreme

Welcome Bioreme

We are thrilled to welcome BIOREME (Integrating data-driven BIOphysical models into REspiratory MEdicine), a pioneering collaborative network based in the UK, as Avicenna new Partner!

News Virtual launch of

Virtual launch of "Toward Good Simulation Practice" book

On May 8, 2024, the virtual launch of "Toward Good Simulation Practice: Best Practices for the Use of Computational Modeling and Simulation (CM&S) in the Regulatory Process of Biomedical Products" took place, marking a significant milestone in regulatory science and industry.

Sign up for our monthly newsletter!

Sign up for our monthly newsletter!

Fill in the fields you find below

Avicenna Alliance is an initiative of:

Avicenna VPH

© 2018-2024 Avicenna Alliance | powered by We Berry